Evidence map›Paper›PMID 35977507›Full record

ArticleCell reports2022

Multiomics assessment of dietary protein titration reveals altered hepatic glucose utilization.

Michael R MacArthur, Sarah J Mitchell, Katia S Chadaideh, J Humberto Treviño-Villarreal, Jonathan Jung, Krystle C Kalafut, Justin S Reynolds, Charlotte G Mann, Kaspar M Trocha, Ming Tao and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Michael R MacArthurDepartment of Health Sciences and Technology, ETH Zürich, 8603 Schwerzenbach, Switzerland. Electronic address: mmacarthur@ethz.ch.
Sarah J MitchellDepartment of Health Sciences and Technology, ETH Zürich, 8603 Schwerzenbach, Switzerland.
Katia S ChadaidehDepartment of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
J Humberto Treviño-VillarrealDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jonathan JungDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Krystle C KalafutDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Justin S ReynoldsDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Charlotte G MannDepartment of Health Sciences and Technology, ETH Zürich, 8603 Schwerzenbach, Switzerland.
Kaspar M TrochaDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ming TaoDepartment of Surgery and the Heart and Vascular Center, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Tay-Zar Aye ChoFeed Technology Office, Charoen Pokphand Group, Bangkok, Thailand.
Anantawat KoontanatechanonFeed Technology Office, Charoen Pokphand Group, Bangkok, Thailand.
Vladimir YeliseyevMassachusetts Host Microbiome Center, Brigham and Women's Hospital, Boston, MA, USA.
Lynn BryMassachusetts Host Microbiome Center, Brigham and Women's Hospital, Boston, MA, USA.
Alban LongchampDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland; Department of Vascular Surgery, CHUV and University of Lausanne, Lausanne, Switzerland.
C Keith OzakiDepartment of Surgery and the Heart and Vascular Center, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Caroline A LewisMetabolite Profiling Core Facility, Massachusetts Institute of Technology, Cambridge, MA, USA.
Rachel N CarmodyDepartment of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
James R MitchellDepartment of Health Sciences and Technology, ETH Zürich, 8603 Schwerzenbach, Switzerland.
Harvard University · USBrigham and Women's Hospital · USETH Zurich · CHCharoenkrung Pracharak Hospital · THMassachusetts Institute of Technology · USUniversity of Lausanne · CH

Funding

Mechanisms of dietary control of the transsulfuration pathway and increased endogenous hydrogen sulfide productionR01DK090629 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI MITCHELL, SARAH JAYNE · 2011 to 2019
$3.0M
Protection against renal ischemic injury by short term dietary restrictionR01AG036712 · NIA · HARVARD SCHOOL OF PUBLIC HEALTH · PI MITCHELL, JAMES R. · 2010 to 2014
$1.6M
Dietary methionine restriction as an exercise mimetic via increased muscle oxidative metabolismF31AG064863 · NIA · HARVARD SCHOOL OF PUBLIC HEALTH · PI MACARTHUR, MICHAEL · 2019 to 2019
$36k
NIA NIH HHS F31 AG064863NIA NIH HHS R01 AG036712NIDDK NIH HHS R01 DK090629
6 · The paper itself

Abstract

Dietary protein restriction (PR) has rapid effects on metabolism including improved glucose and lipid homeostasis, via multiple mechanisms. Here, we investigate responses of fecal microbiome, hepatic transcriptome, and hepatic metabolome to six diets with protein from 18% to 0% of energy in mice. PR alters fecal microbial composition, but metabolic effects are not transferable via fecal transplantation. Hepatic transcriptome and metabolome are significantly altered in diets with lower than 10% energy from protein. Changes upon PR correlate with calorie restriction but with a larger magnitude and specific changes in amino acid (AA) metabolism. PR increases steady-state aspartate, serine, and glutamate and decreases glucose and gluconeogenic intermediates.

Indexed as

GlucoseGlycerolAnimalsAspartic AcidDietary ProteinsGluconeogenesisGlutamic AcidLiverMiceSerineAspartic AcidDietary ProteinsGlucoseGlutamic AcidGlycerolSerineamino acidsATF4calorie restrictionCP: Metabolismdietary restrictiongluconeogenesismetabolic healthprotein restrictionRNA seqserinestable isotope tracing

Identifiers

PMID35977507
PMCPMC9490641
OpenAlexW4292056021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.